This clinical trial with 348 patients with psoriasis aims to investigate the effectiveness of a self-guided online program for patients with psoriasis.
Patients will be randomized and allocated in a 1:1 ratio to either an intervention group, in which they will receive 12-month-access to an online program for psoriasis in addition to treatment as usual (TAU, n = 174), or to a control group, in which they will receive only TAU (n = 174). TAU is defined as any therapy prescribed or recommended by the GP or specialists (e.g. dermatologist, psychiatrist), which may include topical therapy, phototherapy, pharmacotherapy, psychosocial therapy, etc.
Source : Importé depuis le centre
RECRUTEMENT
Profil des participants
Limites d'âge
minimum : 18 ans
Sexe(s) des participants
ALL
Source : Importé depuis le centre
Condition médicale (spécialité visée)
Domaine de recherche
Donnée non disponible
Critères de sélection
Cohortes
Nom
Condition médicale
Traitement
État du recrutement
Online program for psoriasis (GAIA-PSO-01) + TAU
Participants allocated to the intervention group will receive access to an online program for psoriasis (GAIA-PSO-01) in addition to treatment as usual (TAU).
Donnée non disponible
Inconnu
TAU
Participants allocated to the control group will receive access to treatment as usual (TAU).
Donnée non disponible
Inconnu
Online program for psoriasis (GAIA-PSO-01) + TAU
État du recrutement
unknown
Participants allocated to the intervention group will receive access to an online program for psoriasis (GAIA-PSO-01) in addition to treatment as usual (TAU).
TAU
État du recrutement
unknown
Participants allocated to the control group will receive access to treatment as usual (TAU).
Données à jour depuis :
21 août 2025
SITES ET CONTACTS
Centre principal
gaia ag
HAMBURG, GERMANY
Recrutement local
—
FERMÉ
Dernière modification :
21 août 2025
Données à jour depuis :
23 août
Origine des données :
clinicaltrials.gov
* Age ≥ 18 years
* Presence of psoriasis vulgaris or psoriatic arthritis
* Submission of a specialist medical certificate attesting to the presence of at least one of the following ICD-10-GM diagnoses: Psoriasis vulgaris (L 40.0, L 40.7), Psoriatic arthritis (L40.5, M07.x)
* Impaired health-related quality of life (DLQI \> 10)
* Consent to participate
* Sufficient understanding of the German language
Exclusion Criteria:
* Presence of another subtype of psoriasis (pustular psoriasis, guttate psoriasis, inverse psoriasis, erythrodermic psoriasis, or drug-induced psoriasis) or psoriatic arthritis without skin involvement
* Presence of malignancies
* Presence of other chronic diseases with strong negative influence on quality of life
* Currently undergoing psychiatric treatment / current presence of a severe psychiatric diagnosis
* Insufficient language and/or IT skills
Source : Importé depuis le centre
Cohortes
Thérapie ou Intervention proposée
Cohortes
Nom
Condition médicale
Traitement
État du recrutement
Online program for psoriasis (GAIA-PSO-01) + TAU
Participants allocated to the intervention group will receive access to an online program for psoriasis (GAIA-PSO-01) in addition to treatment as usual (TAU).
Donnée non disponible
Inconnu
TAU
Participants allocated to the control group will receive access to treatment as usual (TAU).
Donnée non disponible
Inconnu
Online program for psoriasis (GAIA-PSO-01) + TAU
État du recrutement
unknown
Participants allocated to the intervention group will receive access to an online program for psoriasis (GAIA-PSO-01) in addition to treatment as usual (TAU).
TAU
État du recrutement
unknown
Participants allocated to the control group will receive access to treatment as usual (TAU).
Données à jour depuis :
21 août 2025
Description de l'étude
Description de l'étude
Résumé de l'étude
This clinical trial with 348 patients with psoriasis aims to investigate the effectiveness of a self-guided online program for patients with psoriasis.
Patients will be randomized and allocated in a 1:1 ratio to either an intervention group, in which they will receive 12-month-access to an online program for psoriasis in addition to treatment as usual (TAU, n = 174), or to a control group, in which they will receive only TAU (n = 174). TAU is defined as any therapy prescribed or recommended by the GP or specialists (e.g. dermatologist, psychiatrist), which may include topical therapy, phototherapy, pharmacotherapy, psychosocial therapy, etc.
Source : Importé depuis le centre
Centres participants
Sites
Centres participants
1
centres
GAIA AG
Hamburg
GERMANY
Recrutement local
État du recrutement:
FERMÉ
Source d'information
Dernière modification :
21 août 2025
Données à jour depuis :
23 août
Origine des données :
clinicaltrials.gov